Kaleido Biosciences Risk Adjusted Performance

KLDO -  USA Stock  

USD 5.69  0.03  0.52%

Kaleido Biosciences risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Kaleido Biosciences or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools

Search Technical Indicator 

 
Refresh
Kaleido Biosciences has current Risk Adjusted Performance of 0.083.
RAP 
 = 
(ER[a] - RFR) * STD[b])/STD[b] 
RFR 
 = 
0.083
ER[a] = Expected return on investing in Kaleido Biosciences
RFR = Risk Free Rate of return. Typically T-Bill Rate
STD[b] =   Standard Deviation of selected market or benchmark.

Kaleido Risk Adjusted Performance Relative To Other Indicators

Kaleido Biosciences is rated second overall in risk adjusted performance category among related companies. It is currently under evaluation in maximum drawdown category among related companies reporting about  2,595  of Maximum Drawdown per Risk Adjusted Performance. The ratio of Maximum Drawdown to Risk Adjusted Performance for Kaleido Biosciences is roughly  2,595 
Compare Kaleido Biosciences to competition

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas